MoonLake Immunotherapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -845 | -751 | -745 | -742 |
EBITDA | -69,179 | -60,023 | -66,636 | -53,177 |
EBIT | -70,024 | -60,774 | -67,381 | -53,919 |
Net Income | -69,707 | -62,427 | -69,729 | -55,220 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -66,286 | -58,794 | -44,543 | -54,530 |
Cash | 298,490 | 334,517 | 350,736 | 306,681 |
Basic Shares | 71,273 | 64,463 | 63,369 | 63,282 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -2,616 | -1,384 | -13 | -12 |
EBITDA | -219,846 | -141,706 | -53,752 | -65,049 |
EBIT | -222,462 | -143,091 | -54,123 | -65,061 |
Net Income | -227,318 | -118,935 | -36,007 | -64,506 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 31,458 | |||
Free Cash Flow | -196,042 | -117,106 | -43,062 | -55,909 |
Cash | 334,517 | 180,426 | 451,169 | 39,505 |
Basic Shares | 64,463 | 62,870 | 49,122 | 29,361 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.98 |
2025-12-31 | -$0.92 |
2025-09-30 | -$1.10 |
2025-06-30 | -$0.87 |